News & Updates

STEMI criteria show similar accuracy in right BBB, non-BBB patients
STEMI criteria show similar accuracy in right BBB, non-BBB patients
27 Aug 2024

The ECG criteria used for identifying patients with ST-elevation myocardial infarction (STEMI) demonstrates similar diagnostic accuracy in right bundle branch block (BBB) and non-BBB patients, according to a study.

STEMI criteria show similar accuracy in right BBB, non-BBB patients
27 Aug 2024
Preterm preeclampsia screen-and-prevent strategy to launch across HK’s public hospitals after initial success
Preterm preeclampsia screen-and-prevent strategy to launch across HK’s public hospitals after initial success
27 Aug 2024 byChristina Lau

A screen-and-prevent strategy for preterm preeclampsia (PE), which involves screening in the first trimester and low-dose aspirin prophylaxis for high-risk women in <16–36 weeks of gestation, will be launched in obstetric units of public hospitals across Hong Kong following promising results from a multicentre Asian trial led by the Chinese University of Hong Kong (CUHK) and a pilot programme at the Prince of Wales Hospital (PWH).

Preterm preeclampsia screen-and-prevent strategy to launch across HK’s public hospitals after initial success
27 Aug 2024
GLP-1RAs outperform DPP-4is in preventing hyperkalemia, RASi therapy discontinuation
GLP-1RAs outperform DPP-4is in preventing hyperkalemia, RASi therapy discontinuation
20 Aug 2024 byJairia Dela Cruz

Individuals with type 2 diabetes (T2D) treated in routine clinical care appear to fare better with glucagon-like peptide-1 receptor agonists (GLP-1RAs) than with dipeptidyl peptidase-4 inhibitors (DPP-4is), with GLP-1Ras being associated with lower rates of hyperkalemia and renin-angiotensin system inhibitor (RASi) medication discontinuation, as shown in an observational study.

GLP-1RAs outperform DPP-4is in preventing hyperkalemia, RASi therapy discontinuation
20 Aug 2024